Clinical Pharmacokinetic Monitoring of Free Valproic Acid Levels: A Systematic Review

Methaneethorn J. A systematic review of population pharmacokinetics of valproic acid. Br J Clin Pharmacol. 2018;84:816–34. https://doi.org/10.1111/bcp.13510.

Article  PubMed  PubMed Central  Google Scholar 

Landmark CJ. Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy. CNS Drugs. 2008;22:27–47. https://doi.org/10.2165/00023210-200822010-00003.

CAS  Article  Google Scholar 

Loscher W. Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs 2002;16:669–94. https://doi.org/10.2165/00023210-200216100-00003.

Ding J, Wang Y, Lin W, Wang C, Zhao L, Li X, et al. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation. Clin Pharmacokinet. 2015;54:305–17. https://doi.org/10.1007/s40262-014-0212-8.

CAS  Article  PubMed  Google Scholar 

Tseng Y-J, Huang S-Y, Kuo C-H, Wang C-Y, Wang K-C, Wu C-C. Factors to influence the accuracy of albumin adjusted free valproic acid concentration. J Formos Med Assoc. 2020. https://doi.org/10.1016/j.jfma.2020.09.004.

Article  PubMed  PubMed Central  Google Scholar 

Yu-Ju T, Shih-Ying H, Kuo C-H, Chen-Yu W, Kuo-Chuan W, Wu C-C. Safety range of free valproic acid serum concentration in adult patients. PLoS One San Franc 2020;15:e0238201. https://doi.org/10.1371/journal.pone.0238201.

Bellver MJG, Sánchez MJG, Gonzalez ACA, Buelga DS, Dominguez-Gil A. Plasma protein binding kinetics of valproic acid over a broad dosage range: therapeutic implications. J Clin Pharm Ther. 1993;18:191–7. https://doi.org/10.1111/j.1365-2710.1993.tb00612.x.

Article  Google Scholar 

Free valproic acid assay. CADTHCa 2014. https://www.cadth.ca/free-valproic-acid-assay. Accessed 27 Oct 2020.

Hiemke C, Bergemann N, Clement H, Conca A, Deckert J, Domschke K, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018;51:9–62. https://doi.org/10.1055/s-0043-116492.

CAS  Article  PubMed  Google Scholar 

Kang J-S, Lee M-H. Overview of therapeutic drug monitoring. Korean J Intern Med. 2009;24:1–10. https://doi.org/10.3904/kjim.2009.24.1.1.

Article  PubMed  PubMed Central  Google Scholar 

Gram L. Experimental studies and controlled clinical testing of valproate and vigabatrin. Acta Neurol Scand. 1988;78:241–70. https://doi.org/10.1111/j.1600-0404.1988.tb03655.x.

CAS  Article  PubMed  Google Scholar 

Hermida J, Tutor JC. A theoretical method for normalizing total serum valproic acid concentration in hypoalbuminemic patients. J Pharmacol Sci. 2005;97:489–93. https://doi.org/10.1254/jphs.fpe04007x.

CAS  Article  PubMed  Google Scholar 

Doré M, San Juan AE, Frenette AJ, Williamson D. Clinical importance of monitoring unbound valproic acid concentration in patients with hypoalbuminemia. Pharmacotherapy. 2017;37:900–7. https://doi.org/10.1002/phar.1965.

CAS  Article  PubMed  Google Scholar 

Nasreddine W, Dirani M, Atweh S, Makki A, Beydoun A. Determinants of free serum valproate concentration: a prospective study in patients on divalproex sodium monotherapy. Seizure. 2018;59:24–7. https://doi.org/10.1016/j.seizure.2018.04.012.

Article  PubMed  Google Scholar 

Parent X, Marzullo C. Gutbub AM [Valproic acid: a simple method for the estimation of free serum concentration]. Acide Valproique Estim Simple Conc Serique Libre. 1993;51:649–50.

CAS  Google Scholar 

Drisaldi A, Weeda E, Neyens R, Orvin N, Bonilha L, Campbell Z, et al. Accuracy of valproic acid concentration correction based on serum albumin. Neurocrit Care. 2019;30:301–6. https://doi.org/10.1007/s12028-018-0627-4.

CAS  Article  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71. https://doi.org/10.1136/bmj.n71.

Article  PubMed  PubMed Central  Google Scholar 

Chapter 25: Assessing risk of bias in a non-randomized study. https://training.cochrane.org/handbook/current/chapter-25 Accessed 6 Sep 2021.

Chapter 8: Assessing risk of bias in a randomized trial. https://training.cochrane.org/handbook/current/chapter-08. Accessed 6 Sep 2021.

Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, et al. The CARE guidelines: consensus-based clinical case reporting guideline development. Headache. 2013;53:1541–7. https://doi.org/10.1111/head.12246.

Article  PubMed  Google Scholar 

Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ Evid-Based Med. 2018;23:60–3. https://doi.org/10.1136/bmjebm-2017-110853.

Article  PubMed  PubMed Central  Google Scholar 

Haidukewych D, Rodin EA. Monitoring free valproic acid in epilepsy patients medicated with coanticonvulsants. Ther Drug Monit. 1982;4:209–12.

CAS  Article  Google Scholar 

Roman E, Ponniah P, Lambert J, Buchanan N. Free sodium valproate monitoring. Br J Clin Pharmacol. 1982;13:452–5. https://doi.org/10.1111/j.1365-2125.1982.tb01403.x.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Yu HY. Clinical implications of serum protein binding in epileptic children during sodium valproate maintenance therapy. Ther Drug Monit. 1984;6:414–23.

CAS  Article  Google Scholar 

Bauer LA, Davis R, Wilensky A, Raisys V, Levy RH. Valproic acid clearance: unbound fraction and diurnal variation in young and elderly adults. Clin Pharmacol Ther. 1985;37:697–700.

CAS  Article  Google Scholar 

Froscher W, Burr W, Penin H, Vohl J, Bulau P, Kreiten K. Free level monitoring of carbamazepine and valproic acid: clinical significance. Clin Neuropharmacol. 1985;8:362–71.

CAS  Article  Google Scholar 

Cramer JA, Mattson RH, Bennett DM, Swick CT. Variable free and total valproic acid concentrations in sole- and multi-drug therapy. Ther Drug Monit. 1986;8:411–5.

CAS  Article  Google Scholar 

Kilpatrick CJ, Bury RW, Fullinfaw RO, Moulds RF. Plasma concentrations of unbound valproate and the management of epilepsy. Aust N Z J Med. 1987;17:574–9.

CAS  Article  Google Scholar 

Koerner M, Yerby M, Friel P, McCormick K. Valproic acid disposition and protein binding in pregnancy. Ther Drug Monit. 1989;11:228–30.

CAS  Article  Google Scholar 

Felix S, Sproule BA, Hardy BG, Naranjo CA. Dose-related pharmacokinetics and pharmacodynamics of valproate in the elderly. J Clin Psychopharmacol. 2003;23:471–8.

CAS  Article  Google Scholar 

Sriboonruang T, Panomvana D, Chamchitchun S, Silpakit O. The impact of dosage of sustained-release formulation on valproate clearance and plasma concentration in psychiatric patients: analysis based on routine therapeutic drug monitoring data. J Clin Psychopharmacol. 2011;31:115–9. https://doi.org/10.1097/JCP.0b013e318203b405.

CAS  Article  PubMed  Google Scholar 

Itoh H, Suzuki Y, Fujisaki K, Sato Y, Takeyama M. Correlation between plasma ammonia level and serum trough concentration of free valproic acid in patients with epilepsy. Biol Pharm Bull. 2012;35:971–4. https://doi.org/10.1248/bpb.35.971.

CAS  Article  PubMed  Google Scholar 

Gibbs HG, Zimmerman DE, Shermock KM, Clarke W, Mirski MA, Lewin Ii JJ. Comparison of free fraction serum valproic acid concentrations between inpatients and outpatients. Am J Health Syst Pharm. 2015;72:121–6. https://doi.org/10.2146/ajhp140191.

CAS  Article  PubMed  Google Scholar 

Gidal BE, Collins DM, Beinlich BR. Apparent valproic acid neurotoxicity in a hypoalbuminemic patient. Ann Pharmacother. 1993;27:32–5. https://doi.org/10.1177/106002809302700107.

CAS  Article  PubMed  Google Scholar 

Haroldson J, Kramer L, Wolff D, Lake K. Elevated free fractions of valproic acid in a heart transplant patient with hypoalbuminemia. Ann Pharmacother. 2000;34:183–7. https://doi.org/10.1345/aph.19147.

CAS  Article  PubMed  Google Scholar 

Ginsberg DL. Neurotoxicity with “normal” serum valproic acid levels. Prim Psychiatry. 2005;12:25–6.

Google Scholar 

Sandson NB, Marcucci C, Bourke DL, Smith-Lamacchia R. An interaction between aspirin and valproate: the relevance of plasma protein displacement drug-drug interactions. Am J Psychiatry. 2006;163:1891–6. https://doi.org/10.1176/appi.ajp.163.11.1891.

Article  PubMed  Google Scholar 

Xiong GL, Ferranti J, Leamon MH. Toxic interaction between valproate and oxcarbazepine: a case detected by the free valproate level. J Clin Psychopharmacol. 2008;28:472–3. https://doi.org/10.1097/JCP.0b013e31817ea9e6.

Article  PubMed  Google Scholar 

Chan K, Beran RG. Value of therapeutic drug level monitoring and unbound (free) levels. Seizure. 2008;17:572–5. https://doi.org/10.1016/j.seizure.2007.12.007.

Article  PubMed  Google Scholar 

de Leon J, Kiesel JL, Fleming MW, Strobl B. Valproic acid toxicity associated with low dose of aspirin and low total valproic acid levels: a case report. J Clin Psychopharmacol. 2009;29:509–11. https://doi.org/10.1097/JCP.0b013e3181b4b07c.

Article  PubMed  Google Scholar 

Sleegers MJM, Beutler JJ, Hardon WJ, Berden JHM, Verhave JC, Conemans JMH, et al. Reversible rapidly progressive dementia with parkinsonism induced by valproate in a patient with systemic lupus erythematosus. J Am Geriatr Soc. 2010;58:799–801. https://doi.org/10.1111/j.1532-5415.2010.02795.x.

Article  PubMed  Google Scholar 

de Maat MMR, van Leeuwen HJ, Edelbroek PM. High unbound fraction of valproic acid in a hypoalbuminemic critically ill patient on renal replacement therapy. Ann Pharmacother. 2011;45: e18. https://doi.org/10.1345/aph.1P308.

Article  PubMed  Google Scholar 

Sparla S, Hogeman P, van Gemert M, Swart E, Malingre M. Valproic acid during pregnancy: Case report of a child with congenital malformations due to fetal valproate syndrome, and a high unbound serum level of valproic acid at birth. Int J Epilepsy. 2017;4:94–7. https://doi.org/10.1016/j.ijep.2016.11.001.

Article  Google Scholar 

Dautzenberg G, Nederlof M, Beekman A, Egberts T, Heerdink ER. Severe cognitive impairment associated with a high free but therapeutic total concentration of valproic acid due to hypoalbuminemia in an older patient with bipolar disorder. J Clin Psychopharmacol. 2018;38:265–8. https://doi.org/10.1097/JCP.0000000000000872.

CAS  Article 

留言 (0)

沒有登入
gif